Scott Huntington, MD

• Multiple Myeloma

Scott Huntington, MD, MPH is a physician and researcher at Yale School of Medicine specializing in the care of patients with lymphoma and chronic lymphocytic leukemia.

Dr. Huntington diagnoses and treats common lymphoma disorders, including chronic lymphocytic leukemia (CLL), Hodgkin lymphoma, and mantle cell lymphoma, in addition to rare types such as Hairy cell leukemia, primary mediastinal B-cell lymphoma (PMBCL) and gray zone lymphoma. Dr. Huntington also has leadership roles as the Chief Quality Officer for Smilow Cancer Center and the Firm Chief for the inpatient blood cancer service.

Dr. Huntington is an active researcher at Yale’s Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, where he leads research focused on improving the delivery of complex cancer treatment and improving patient outcomes. He is also an active clinical trial investigator, evaluating novel cancer therapeutics in individuals with CLL, Hodgkin lymphoma, and B cell non-Hodgkin lymphomas.

A recipient of the Conquer Cancer Foundation of ASCO Merit Award, Armstrong Founders Award, and 40 under 40 in Cancer, Dr. Huntington is an associate professor of internal medicine at Yale University School of Medicine.